SUBSCRIBE
SUBSCRIBE

Lonza Group Ltd. to Invest $150 Million in Genome Valley

May 22, 2009 | 
1 min read
PharmaBiz -- Switzerland-based Lonza, one of the global biopharmaceutical giants, would make an investment of US $150 million (around Rs 750 crore) for two major projects in Genome Valley, which is located at the outskirts of Hyderabad.
Asia
Lonza
MORE ON THIS TOPIC
Business people shaking hand in China.
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
February 10, 2026
 · 
1 min read
 · 
Tristan Manalac
3d render scene
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
February 2, 2026
 · 
8 min read
 · 
Annalee Armstrong
Business people shaking hand in China.
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
January 30, 2026
 · 
2 min read
 · 
Tristan Manalac